Immortal Dragons Ignites a Revolution in Longevity with a $40M War Chest for Radical Life Extension

Immortal Dragons, a visionary, purpose-driven longevity fund headquartered in Singapore, has officially launched with $40 million in assets under management, heralding a new era of investment in radical life extension technologies. This is not just another venture fund; it is a declaration of war against aging and a testament to the profound belief that death itself is a technical challenge that can be overcome through human ingenuity and audacious science.

At its very core, Immortal Dragons is animated by a philosophy that prioritizes transformative impact over mere financial returns. This conviction is the guiding star for every investment, propelling the fund to champion the most ambitious and groundbreaking projects in the longevity sector.

Fueling the Moonshots of Tomorrow

Immortal Dragons is casting a wide net, targeting a diverse and exciting array of technologies that are poised to redefine the boundaries of human lifespan. With over 15 startups already in its portfolio, the fund is strategically investing across several key pillars:

• • Replacement & Regeneration: Championing pioneering research in xenotransplantation, cryopreservation, and the regeneration of biological tissues and organs.
• • Gene Therapy: Backing advanced gene therapies that target the root causes of aging and age-related diseases.
• • 3D Bioprinting: Fueling the development of 3D bioprinting for creating functional tissues and organs.
• • Longevity Infrastructure: Building the foundational ecosystem for longevity science, including accelerated clinical trials and innovative regulatory sandboxes.

Boyang Wang, the brilliant founder of Immortal Dragons, articulated the fund’s philosophy with elegant clarity: "Whether it’s cutting-edge science or creating better environments for research, we need to see the opportunity for real impact." This unwavering commitment to impact guides the fund to support what Boyang calls "moonshot projects that push the boundaries of science, while infrastructure work – like special economic zones – creates the conditions for broader success."

Capital with a Conscience: The Power of Purpose-Driven Investment

Operating with the agility and conviction of a single-LP structure, Immortal Dragons directs its own capital toward the projects that ignite its passion, enabling swift and decisive action. This unique model empowers the fund to support transformative research that traditional venture capital, with its more conservative outlook, might shy away from.

"We are a purpose-driven fund, and the key implication is that Immortal Dragons values impact over economic returns," Boyang stated in a recent interview. "I’m investing in the field of longevity because I want to see progress and breakthroughs in the sector."

This is not just rhetoric for Boyang Wang; it is a deeply held personal conviction. In a bold and inspiring move, he is among the first 300 global recipients of Minicircle’s follistatin gene therapy, a powerful demonstration of the fund's willingness to embrace and personally test the science it champions. "The gene therapy is a personal attempt, but this does reflect our risk profile and support for the cause," Boyang explained. "We have a strong motivation to support the first wave of longevity companies to make a profit, so as to propel the investment flywheel."

A Global Ambassador for the Longevity Revolution

Immortal Dragons’ mission extends far beyond the realm of investment. The fund is a passionate and dedicated global advocate for the longevity revolution, actively engaging in educational outreach and community-building initiatives. From translating the talks of scientific leaders and publishing longevity-themed books to hosting a leading Chinese-language longevity podcast and sponsoring key industry events, Immortal Dragons is building a robust global ecosystem for this nascent field.

This tireless advocacy has earned the praise of leading academics and pioneers in the field.

Professor Peter Lidsky of the City University of Hong Kong's Biomedical Science department commented, “I was excited to meet the Immortal Dragons team... These are young, brave and energetic people committed to resolving the main challenge humanity faces: aging. Their foundation helped me a lot in translating one of my lectures to Chinese, and I hope our collaboration will prosper in the future.”

Aubrey de Grey, the renowned president of the LEV Foundation, added, "It has been a great pleasure to get to know the Immortal Dragons team. I have been frustrated for many years that there has been too little longevist activity in China, and I am delighted that that is now changing, with the work of a group that is bringing my and others’ work to the Chinese public. I am also very happy that Immortal Dragons are investing in promising longevity startups.”

With deep roots in both the East and the West, Immortal Dragons is uniquely positioned to bridge markets, capital, and research, creating a truly global movement. The fund stands as a powerful testament to the transformative power of purpose-driven investment, a beacon of hope in the quest to extend and enhance the human lifespan.

About Immortal Dragons:

Immortal Dragons (https://www.id.life/) is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, high-impact technologies and currently supports more than 15 portfolio companies. Beyond conventional investments, the fund advances longevity advocacy through book translation and publishing, translation of longevity leaders' talks, hosting a leading Chinese-language longevity podcast, and providing sponsorships and grants to longevity initiatives and conferences.

For Press Inquiries:
Boyang Wang
Founder, Immortal Dragons
press@id.life